Our state-of-the-art facility in the U.S. 

Rentschler Biopharma Manufacturing Center Milford US

In the summer of 2021, we broke ground for a new facility in order to double our commercial manufacturing capability. The new state-of-the-art manufacturing line represents the largest expansion in our 150-year history. As part of the existing facility, it adds 22,000 square feet of manufacturing cleanroom space while housing four 2,000 L single-use bioreactors. 

Growing with our manufacturing footprint, the site includes expanded quality control (QC), development, and warehousing capabilities. Importantly, this new state-of-the-art facility is highly automated, leveraging industry 4.0 solutions. It provides innovative digital and analytical services, such as advanced analytics yield optimization, augmented/virtual reality-enabled operations and no-touch batch releases.

Biopharmaceutical Services

From concept to market: with our full-service offering, we are your CDMO companion.

Rentschler Biopharma CDMO expert support at any stage

Analytical Development

Read more

Rentschler Biopharma Process Development Services

Process Development

Read more

Rentschler Biopharma CDMO formulation development with Leukocare

Formulation Development

Read more

Rentschler Biopharma CDMO 3000L stainless steel bioreactor

cGMP Manufacturing

Read more

Rentschler Biopharma CDMO Xpert alliance Vdsc automatic vial filler

Xpert Alliance

Read more

Rentschler Biopharma CDMO cGMP manufacturing at state-of-the-art facilities

Client Program Management

Read more

Rentschler Biopharma CDMO industry-leading consulting services for regulatory success

Regulatory Affairs

Read more

Our offering

We would love to have your talent - join our team in Milford!


Rentschler Biopharma Inc.
27 Maple Street 
Milford, MA 01757



Email: info@rentschler-biopharma.com 
Phone: +1 508 282-5800